Company
Scribe Therapeutics
- Headquarters:
- Alameda, CA
Description
Engineers CRISPR-based therapeutics by modifying natural CRISPR systems, with treatments focused on cardiometabolic disease and collaborations extending the approach to other therapeutic areas.
Related
Mammoth BiosciencesDevelops in vivo gene-editing therapeutics, engineers CRISPR-Cas systems and editing strategies, and provides CRISPR-based detection…
ProfluentBuilds AI systems that design proteins from natural scaffolds or from scratch for therapeutic, industrial enzyme, and other protein design…
Caribou Biosciences ($CRBU)Develops genome-edited allogeneic CAR-T cell therapies using CRISPR and chRDNA technology for patients with hematologic malignancies and…
InsitroBuilds AI systems using automated cellular experiments and population genetics to identify causal disease targets and design therapeutics…
CRISPR Therapeutics ($CRSP)CRISPR Therapeutics develops CRISPR-based gene-editing therapies across hemoglobinopathies, oncology, diabetes, and cardiovascular disease,…
Editas Medicine ($EDIT)Develops CRISPR-based gene editing medicines, including in vivo approaches, for people with serious diseases where modifying genes may…
Aptos OrbitalBuilds spacecraft hardware integrating space-hardened computing, persistent communications, and cloud connectivity for satellite operators…
Numab TherapeuticsNumab Therapeutics engineers multispecific antibodies. Its work supports a therapeutic pipeline based on antibody engineering and Swiss…
ARTHEX BIOTECH S.L.Develops RNA-based therapeutics, specifically anti-miR oligonucleotides for myotonic dystrophy and other diseases, used by researchers and…
Generate BiomedicinesDevelops programmable protein-based medicines using generative biology, with clinical development and IND work focused on immunology and…
LabGenius TherapeuticsLabGenius Therapeutics develops EVA, an automated platform for discovering and optimizing complex therapeutic antibodies.
ONK TherapeuticsONK Therapeutics develops ready-made natural killer cell therapies.